NO20005718D0 - Sammensetning for hud - Google Patents

Sammensetning for hud

Info

Publication number
NO20005718D0
NO20005718D0 NO20005718A NO20005718A NO20005718D0 NO 20005718 D0 NO20005718 D0 NO 20005718D0 NO 20005718 A NO20005718 A NO 20005718A NO 20005718 A NO20005718 A NO 20005718A NO 20005718 D0 NO20005718 D0 NO 20005718D0
Authority
NO
Norway
Prior art keywords
compositions
conjugated
well
eczema
skin
Prior art date
Application number
NO20005718A
Other languages
English (en)
Other versions
NO20005718A (no
NO310176B1 (no
Inventor
Jan Wadstein
Original Assignee
Wadlund As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wadlund As filed Critical Wadlund As
Priority to NO20005718A priority Critical patent/NO310176B1/no
Publication of NO20005718D0 publication Critical patent/NO20005718D0/no
Publication of NO310176B1 publication Critical patent/NO310176B1/no
Publication of NO20005718A publication Critical patent/NO20005718A/no
Priority to EP01993455A priority patent/EP1341517B1/en
Priority to US10/416,671 priority patent/US7557094B2/en
Priority to DE60122927T priority patent/DE60122927T2/de
Priority to ES01993455T priority patent/ES2272566T3/es
Priority to PCT/NO2001/000437 priority patent/WO2002038123A1/en
Priority to PT01993455T priority patent/PT1341517E/pt
Priority to DK01993455T priority patent/DK1341517T3/da
Priority to AT01993455T priority patent/ATE338533T1/de
Priority to AU2002216473A priority patent/AU2002216473A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005718A 2000-11-13 2000-11-13 Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne NO310176B1 (no)

Priority Applications (10)

Application Number Priority Date Filing Date Title
NO20005718A NO310176B1 (no) 2000-11-13 2000-11-13 Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne
AU2002216473A AU2002216473A1 (en) 2000-11-13 2001-11-01 A skin cream composition
AT01993455T ATE338533T1 (de) 2000-11-13 2001-11-01 Hautcremezusammensetzung
DK01993455T DK1341517T3 (da) 2000-11-13 2001-11-01 Et hudcremepræparat
US10/416,671 US7557094B2 (en) 2000-11-13 2001-11-01 Skin cream composition
EP01993455A EP1341517B1 (en) 2000-11-13 2001-11-01 A skin cream composition
DE60122927T DE60122927T2 (de) 2000-11-13 2001-11-01 Hautcremezusammensetzung
ES01993455T ES2272566T3 (es) 2000-11-13 2001-11-01 Una composicion de crema cutanea.
PCT/NO2001/000437 WO2002038123A1 (en) 2000-11-13 2001-11-01 A skin cream composition
PT01993455T PT1341517E (pt) 2000-11-13 2001-11-01 Composição em creme para a pele

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20005718A NO310176B1 (no) 2000-11-13 2000-11-13 Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne

Publications (3)

Publication Number Publication Date
NO20005718D0 true NO20005718D0 (no) 2000-11-13
NO20005718A NO20005718A (no) 2001-06-05
NO310176B1 NO310176B1 (no) 2001-06-05

Family

ID=19911788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005718A NO310176B1 (no) 2000-11-13 2000-11-13 Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne

Country Status (10)

Country Link
US (1) US7557094B2 (no)
EP (1) EP1341517B1 (no)
AT (1) ATE338533T1 (no)
AU (1) AU2002216473A1 (no)
DE (1) DE60122927T2 (no)
DK (1) DK1341517T3 (no)
ES (1) ES2272566T3 (no)
NO (1) NO310176B1 (no)
PT (1) PT1341517E (no)
WO (1) WO2002038123A1 (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114652636A (zh) * 2022-03-10 2022-06-24 广东丸美生物技术股份有限公司 一种抗皱修复组合物及其制备方法和包含该组合物的化妆品

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO310176B1 (no) * 2000-11-13 2001-06-05 Wadlund As Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne
ITMI20010347A1 (it) * 2001-02-21 2002-08-21 Grisotech S A Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale
DE10253042A1 (de) * 2002-11-14 2004-06-03 Wacker-Chemie Gmbh Kosmetische Zubereitung enthaltend einen Komplex aus Cyclodextrin und Vitamin F
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
WO2005018632A1 (en) * 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
ES2310948B2 (es) * 2005-02-25 2009-09-16 Universidade De Santiago De Compostela Procedimiento de obtencion de hidrogeles de ciclodextrinas con glicidileteres, las composiciones obtenidas y sus aplicaciones.
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
US20060240116A1 (en) * 2005-04-22 2006-10-26 David Jolley Bioactive factors in wound healing topical compositions and methods
US20070116778A1 (en) * 2005-11-22 2007-05-24 Fierro Arthur A Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases
ITRM20060108A1 (it) * 2006-03-03 2007-09-04 Colella Gino Composizioni a base di melatonina e sostanze immunostimolanti
NO326950B1 (no) * 2006-09-20 2009-03-16 Pharma Medico Res Ltd Kombinasjon av et glukokortikoid og et β-syklodekstrin konjugert vitamin A derivat-kompleks
EP1958639A1 (en) 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans for the treatment of nail inflammatory diseases
US9393261B2 (en) * 2011-07-22 2016-07-19 Body Glide LLC Antimicrobial anti-chafing chelated silver oxide compound
US9132296B2 (en) 2007-05-17 2015-09-15 Ag Essence Antimicrobial solution and methods of making and using the same
US20080312174A1 (en) * 2007-06-05 2008-12-18 Nitto Denko Corporation Water soluble crosslinked polymers
CA2698812A1 (en) * 2007-09-14 2009-03-19 Nitto Denko Corporation Drug carriers
KR101123366B1 (ko) 2008-06-26 2012-03-23 (주)바이오제닉스 우수한 안정성을 갖는 항산화제와 키토산과의 복합체
CA2773277C (en) 2008-09-12 2019-03-26 Nanoko A/S Colostrum composition
KR101346661B1 (ko) * 2010-11-15 2014-02-06 부경대학교 산학협력단 키토올리고당을 포함하는 피부 노화 방지용 화장료 조성물
WO2014092747A1 (en) * 2012-12-12 2014-06-19 William Wingfield Metal oxide complexes and infusion of complexes into polymer compounds
US20140234433A1 (en) * 2013-02-15 2014-08-21 Nicholas V. Perricone Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675535A5 (no) * 1988-11-28 1990-10-15 Nestle Sa
FR2651131B1 (fr) 1989-08-23 1994-05-20 Roussel Uclaf Nouvelles compositions cosmetiques contenant du chitosane et de la glucosamine.
SE9300971D0 (sv) * 1993-03-24 1993-03-24 Jan Wadstein Hudvaardskomposition
EP0637450A3 (en) * 1993-08-04 1995-04-05 Collagen Corp Method and composition for resuscitation of hereditary tissue.
DE19537297A1 (de) * 1995-07-07 1997-01-09 Paerson & Co Gmbh & Co Kosmetische Präparate mit Wachstumsfaktoren hergestellt aus Milch und Kolostrum von Kühen und Stuten
NO304009B1 (no) 1997-02-04 1998-10-12 Gunnar Volden Hudpreparat
US6019990A (en) * 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations
EP1041979A4 (en) 1997-12-23 2001-10-04 Dcv Inc ESTERS OF CONJUGATED LINOLEIC ACID OR CONJUGATED LINOLENIC ACID
EP1082096A1 (en) 1998-03-31 2001-03-14 Natural ASA Skin treatment compositions and the use thereof
GB9828379D0 (en) 1998-12-22 1999-02-17 Unilever Plc Skin care composition
GB9828380D0 (en) 1998-12-22 1999-02-17 Unilever Plc Skin lightening composition
EP1180940A2 (de) * 1999-03-31 2002-02-27 KAPITZ, Carl-Heinz Wirkstoff und wirkstoffkombination für mensch und tier
GB9918025D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
NO310176B1 (no) * 2000-11-13 2001-06-05 Wadlund As Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114652636A (zh) * 2022-03-10 2022-06-24 广东丸美生物技术股份有限公司 一种抗皱修复组合物及其制备方法和包含该组合物的化妆品
CN114652636B (zh) * 2022-03-10 2023-11-17 广东丸美生物技术股份有限公司 一种抗皱修复组合物及其制备方法和包含该组合物的化妆品

Also Published As

Publication number Publication date
NO20005718A (no) 2001-06-05
ES2272566T3 (es) 2007-05-01
US20040043963A1 (en) 2004-03-04
NO310176B1 (no) 2001-06-05
DK1341517T3 (da) 2007-01-08
EP1341517A1 (en) 2003-09-10
US7557094B2 (en) 2009-07-07
ATE338533T1 (de) 2006-09-15
WO2002038123A1 (en) 2002-05-16
DE60122927T2 (de) 2007-05-24
EP1341517B1 (en) 2006-09-06
AU2002216473A1 (en) 2002-05-21
DE60122927D1 (de) 2006-10-19
PT1341517E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
NO20005718D0 (no) Sammensetning for hud
AU6720000A (en) New process for the preparation of conjugated linoleic acid (cla)
ATE412417T1 (de) Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten
GB2394662A (en) Topical composition for treating pain
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
WO2007061625A3 (en) A therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
CA2396186A1 (en) Agents for the treatment of skin disorders
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
AU5792399A (en) Stable ascorbic acid preparation for topical use
WO2005025486A3 (en) Skincare compositions comprising salicyclic acid
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
DK284386A (da) Farmaceutisk praeparat mod hudlidelser
MXPA06013179A (es) Composicion anti-acne para el cuidado de la piel y articulo para el cuidado de la piel.
PT1809383E (pt) Composições cosméticas
WO2004084829A3 (en) Esterified fatty acid composition
ATE235885T1 (de) Antioxidative hautpflegemittel
WO2005063195A3 (en) Compositions comprising vitamins and/or derivatives thereof stabilised with olea europea extract and/or ionene polymers
ES2541379A1 (es) Cosmética natural de bellota
IL112019A (en) Pharmaceutical compositions for topical treatment of psoriasis
DK1247521T3 (da) Anvendelse af biguanid- og pyrimidin-derivater til fremstilling af topiske hudplejetilberedninger
WO2017001707A1 (es) Cosmética de aceite de bellota
WO2003103625A3 (en) DERMOCOSMETIC TREATMENT WITH METABOLIC PHOSPHOLIPIDS
WO2004093832A3 (fr) Composition cosmetique ou pharmaceutique comprenant l’association d’au moins un diacylglycerol et d’au moins un alcool gras
FI20000956A (fi) Kosmeettinen tai ihonhoidollinen voidekoostumus, sen valmistusmenetelmä ja käyttö

Legal Events

Date Code Title Description
MK1K Patent expired